Group Leader
                                            Mª Jesús Cruz Carmona, Jaume Ferrer Sancho                                        
                                            Principal Investigator (PI)
                                            Miriam Barrechenguren Fernández, Cristina Berastegui Garcia, Susana Gómez Olles, Manuel López Meseguer, Marc Miravitlles Fernández, Victor Monforte Torres, Xavier Muñoz Gall, Iñigo Ojanguren Arranz, Eva Polverino, Berta Saez Gimenez,                                        
                                            Researchers
                                            Antonio Álvarez Fernández, Irene Belmonte Mula, Carlos Bravo Masgoret, David Clofent Alarcón, Mario Culebras Amigo, María Luiza De Souza Galvao, Mª Ángeles Jiménez Fuentes, Mª José Jurado Luque, Karina Loor Reyes, Sergi Martí Beltran, Cèlia Milà Augé, Mercedes Pallero Castillo, Mª Antonia Ramón Belmonte, Esther Rodríguez González, Christian Romero Mesones, Odile Romero Santo-Tomas, Berta Sáez Gimenez, Gabriel Sampol Rubio, Julia Sampol Sirvent, Ana Villar Gómez                                        
                                            PhD Students
                                            Meritxell Boada Pérez, David Espejo Castellanos, Almudena Felipe, Galo Granados Rosales, Marc Massa Gómez, David Soler Segovia, Alex Gabriela Nuñez Bubón, Eva Revilla Lopez, Victoria Ruiz de Miguel, Letizia Traversi                                        
                                        Lab Technicians
                                            Victor Guerra Ruiz, Gerard Orriols, Sonia López Rodríguez, Rosa Lloria Verges, Montserrat Murillo Andrés, Jordi Rabadan Carnicero                                        
                                        Nursing and Technical Staff
                                            Roser Escobar Fornieles, Georgina Farago                                        
103
PUBLICATIONS
56.3%
%Q1
925
IMPACT FACTOR
8.98
AVERAGE IMPACT FACTOR
SELECTED ARTICLES
                                                        Sánchez-Díez S, Munoz X, Ojanguren I, Romero-Mesones C, Espejo D, Villar A, Gómez-Olles S, Cruz MJ.
                                                        YKL-40 and KL-6 Levels in Serum and Sputum of Patients Diagnosed With Hypersensitivity Pneumonitis
                                                        J Allergy Clin Immunol Pract. 2022 Sep;10(9):2414-2423.
                                                        DOI: doi: 10.1016/j.jaip.2022.06.031
                                                        IF: 11.022
                                                    
                                                        Huang JT, Cant E, Keir HR, Barton AK, Kuzmanova E, Shuttleworth M, Pollock J, Finch S, Polverino E, Bottier M, Dicker AJ, Shoemark A, Chalmers JD
                                                        Endotyping COPD, Bronchiectasis and the ‘COPD-bronchiectasis Association
                                                        Am J Respir Crit Care Med. 2022 Aug 15;206(4):417-426
                                                        DOI: doi: 10.1164/rccm.202108-1943OC
                                                        IF: 30.53
                                                    
                                                        Gottlieb J, Lepper PM, Berastegui C, Montull B, Wald A, Parmar J, Magnusson JM, Schonrath F, Laisaar T, Michel S, Larsson H, Vos R, Haneya A, Sandhaus T, Verschuuren E, le Pavec J, Tikkanen J, Hoetzenecker K
                                                        Lung transplantation for acute respiratory distress syndrome – a retrospective European Cohort Study
                                                        Eur Respir J. 2022 Jun 30;59(6)
                                                        DOI: doi: 10.1183/13993003.02078-2021
                                                        IF: 33.801
                                                    
                                                        Cruz-Utrilla A, Perez-Olivares C, Martinez-Menaca A, Lopez-Meseguer M, Escribano-Subias P
                                                        Phenotypes of idiopathic pulmonary arterial hypertension.
                                                        Lancet Respir Med. 2022 Oct;10(10):e87
                                                        DOI: doi: 10.1016/S2213-2600(22)00290-9
                                                        IF: 102.64
                                                    
                                                        Culebras M, Loor K, Sansano I, Persiva O, Clofent D, Polverino E, Felipe A, Osorio J, Munoz X, Alvarez A, Andreu J, Arjona M, Berastegui C, Barrecheguren M, Cardoso J, Cruz MJ, De Souza ML, Espejo D, Granados G, Jimenez MA, Lopez M, Ojanguren I, Pallero M, Ramon MA, Ramon Y Cajal S, Revilla EM, Romero C, Saez B, Sampol J, Velez E, Villar A
                                                        Histological Findings in Transbronchial Cryobiopsies Obtained From Patients After COVID-19
                                                        Chest. 2022 Mar;161(3):647-650.
                                                        DOI: doi: 10.1016/j.chest.2021.09.016.
                                                        IF: 11.39
                                                    
                                            Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome (EXIMIOUS)
                                            Principal Investigator: María Jesus Cruz, Xavier Muñoz Gall
                                                                                            Agency: European Commission (EXIMIOUS_H2020_SC1-BHC-2019)
                                                                                                                                        Funding: 395,500 €
                                                                                                                                        Period: 2020 - 2024
                                                                                    
                                            iABC: Inhaled antibiotics in bronchiectasis and cystic fibrosis
                                            Principal Investigator: Eva Polverino
                                                                                            Agency: The Innovative Medicines Initiative (IABC_IMI2-2015)
                                                                                                                                        Funding: 121,599 €
                                                                                                                                        Period: 2017 - 2023
                                                                                    
                                            Characterisation and risk factors of PULmonary SEquelae in patients discharged after COVID-19 pneumonia (PULSE-COVID).
                                            Principal Investigator: Xavier Muñoz Gall
                                                                                            Agency: Instituto de Salud Carlos III. Fis PI21/01046
                                                                                                                                        Funding: 132,520 €
                                                                                                                                        Period: 2022 - 2024
                                                                                    
                                            MicroRNA expression profiles in asthmatic patients with different disease phenotypes exposed to pollutants.
                                            Principal Investigator: María Jesús Cruz Carmona
                                                                                            Agency: Instituto de Salud Carlos III. Fis PI21/01346
                                                                                                                                        Funding: 141,570 €
                                                                                                                                        Period: 2022 - 2024
                                                                                    
                                            Asthmatic exacerbations of viral origin and their impact on different asthmatic phenotypes: Etiology, immunological and inflammatory mechanisms.
                                            Principal Investigator: Iñigo Ojanguren Arranz
                                                                                            Agency: Instituto de Salud Carlos III. Fis PI21/01100
                                                                                                                                        Funding: 75,020 €
                                                                                                                                        Period: 2022 - 2024